Advertisement
Singapore markets open in 8 hours 24 minutes
  • Straits Times Index

    3,326.28
    +12.14 (+0.37%)
     
  • S&P 500

    5,453.33
    +5.46 (+0.10%)
     
  • Dow

    39,025.97
    -385.24 (-0.98%)
     
  • Nasdaq

    17,664.80
    +167.98 (+0.96%)
     
  • Bitcoin USD

    61,543.30
    +684.90 (+1.13%)
     
  • CMC Crypto 200

    1,282.13
    +33.01 (+2.64%)
     
  • FTSE 100

    8,247.79
    -33.76 (-0.41%)
     
  • Gold

    2,332.20
    -12.20 (-0.52%)
     
  • Crude Oil

    81.04
    -0.59 (-0.72%)
     
  • 10-Yr Bond

    4.2530
    +0.0050 (+0.12%)
     
  • Nikkei

    39,173.15
    +368.50 (+0.95%)
     
  • Hang Seng

    18,072.90
    +45.19 (+0.25%)
     
  • FTSE Bursa Malaysia

    1,585.38
    -4.28 (-0.27%)
     
  • Jakarta Composite Index

    6,882.70
    -6.46 (-0.09%)
     
  • PSE Index

    6,299.05
    +26.59 (+0.42%)
     

Phreesia (PHR) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates

Phreesia (PHR) reported $83.85 million in revenue for the quarter ended April 2023, representing a year-over-year increase of 32.4%. EPS of -$0.70 for the same period compares to -$0.99 a year ago.

The reported revenue compares to the Zacks Consensus Estimate of $80.64 million, representing a surprise of +3.97%. The company delivered an EPS surprise of +12.50%, with the consensus EPS estimate being -$0.80.

While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.

Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.

ADVERTISEMENT

Here is how Phreesia performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:

  • Average healthcare services Clients: 3309 versus 3297.05 estimated by four analysts on average.

  • Patient payment volume: $1.02 billion versus $1.03 billion estimated by four analysts on average.

  • Average revenue per healthcare services client: $18.78 million versus $18.69 million estimated by three analysts on average.

  • Revenus- Subscription and related services: $37.89 million compared to the $37.72 million average estimate based on five analysts. The reported number represents a change of +30.2% year over year.

  • Revenus- Network solutions: $21.71 million compared to the $20.01 million average estimate based on five analysts. The reported number represents a change of +46% year over year.

  • Revenus- Payment processing fees: $24.25 million compared to the $23.84 million average estimate based on five analysts. The reported number represents a change of +25.1% year over year.

View all Key Company Metrics for Phreesia here>>>

Shares of Phreesia have returned -6.1% over the past month versus the Zacks S&P 500 composite's +1.1% change. The stock currently has a Zacks Rank #4 (Sell), indicating that it could underperform the broader market in the near term.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Phreesia, Inc. (PHR) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research